Sofinnova Partners was founded in 1972 in Paris, making it one of the oldest and most established life sciences VCs in Europe. The firm recently raised approximately €1.5B across Capital XI (€650M) and Biovelocita II (€165M), investing from seed to growth across biotech, medtech, and sustainability.
The portfolio spans 500+ companies over five decades, including Actelion, Genfit, Poxel, Valneva, ...
London, United Kingdom
Melbourne, Australia
Leverkusen, Germany
Amsterdam, Netherlands
Boston, United States
Bala Cynwyd, United States